circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
Authors
Keywords
bladder cancer, circNR3C1, BRD4, endogenous blocker
Journal
Molecular Therapy-Nucleic Acids
Volume 22, Issue -, Pages 510-519
Publisher
Elsevier BV
Online
2020-09-17
DOI
10.1016/j.omtn.2020.09.016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors
- (2019) Yair Lotan et al. EUROPEAN UROLOGY
- The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors
- (2019) Aubrey L. Miller et al. EBioMedicine
- Brd4 and P300 Confer Transcriptional Competency during Zygotic Genome Activation
- (2019) Shun Hang Chan et al. DEVELOPMENTAL CELL
- CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression
- (2019) Fuxin Zheng et al. CANCER LETTERS
- The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis
- (2019) Ling Fang et al. CANCER LETTERS
- Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging
- (2019) Maximilian C. Kriegmair et al. EUROPEAN UROLOGY
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells
- (2019) Giulia Gobbi et al. ONCOGENE
- BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
- (2018) Hatice Gulcin Ozer et al. Cancer Discovery
- Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes
- (2018) Yajun Chen et al. CELL DEATH AND DIFFERENTIATION
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis
- (2018) Fei Xie et al. Molecular Cancer
- BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC
- (2017) Mingchen Ba et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27 Kip1
- (2017) Gang Luo et al. MOLECULAR CANCER RESEARCH
- Sensing Self and Foreign Circular RNAs by Intron Identity
- (2017) Y. Grace Chen et al. MOLECULAR CELL
- BRD4 inhibitors block telomere elongation
- (2017) Steven Wang et al. NUCLEIC ACIDS RESEARCH
- Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
- (2017) Lian Dee Ler et al. Science Translational Medicine
- CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
- (2016) Mark L. McCleland et al. JOURNAL OF CLINICAL INVESTIGATION
- BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4
- (2016) Qiang Zhang et al. STRUCTURE
- Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
- (2016) A. Stathis et al. Cancer Discovery
- EZH2 in Bladder Cancer, a Promising Therapeutic Target
- (2015) Mónica Martínez-Fernández et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
- (2015) Shenghua Liu et al. PLoS One
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- EZH2: Not EZHY (Easy) to Deal
- (2014) Gauri Deb et al. MOLECULAR CANCER RESEARCH
- Chromatin Reader Brd4 Functions in Ig Class Switching as a Repair Complex Adaptor of Nonhomologous End-Joining
- (2014) Andre Stanlie et al. MOLECULAR CELL
- Detecting and characterizing circular RNAs
- (2014) William R Jeck et al. NATURE BIOTECHNOLOGY
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release
- (2013) Wen Liu et al. CELL
- Natural RNA circles function as efficient microRNA sponges
- (2013) Thomas B. Hansen et al. NATURE
- Circular RNAs are a large class of animal RNAs with regulatory potency
- (2013) Sebastian Memczak et al. NATURE
- Bridging the gap between qualitative and quantitative colocalization results in fluorescence microscopy studies
- (2013) Vadim Zinchuk et al. Scientific Reports
- Cell-Type Specific Features of Circular RNA Expression
- (2013) Julia Salzman et al. PLoS Genetics
- Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients
- (2013) Zhi-Ling Zhang et al. Chinese Journal of Cancer
- Urothelial carcinoma of the bladder: definition, treatment and future efforts
- (2011) Sandip M. Prasad et al. Nature Reviews Urology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search